Skip to content

Study of the use of caffeine in performance in cyclists.

Effect of chronic and / or acute Caffeine in performance on the test time-trial on cyclists

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-5745nv
Enrollment
Unknown
Registered
2019-04-12
Start date
2018-11-28
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Muscle Fatigue

Interventions

18 cyclists will be recruited. The experimental conditions will involve chronic supplementation of placebo (250 mg of starch) and / or caffeine (6 mg.kg body weight) in the period of 4 consecutive day
placebo / placebo (PP), placebo / caffeine (CP) and caffeine / caffeine (CC). A washout of at least 2 days (48 hours) and a maximum of 5 days between the experimental trials shall be established.
Dietary supplement
SP6.051.227

Sponsors

Universidade Federal do Rio de Janeiro (UFRJ-Campus Macaé)
Lead Sponsor
Universidade Federal do Rio de Janeiro (UFRJ-Campus Macaé)
Collaborator

Eligibility

Sex/Gender
Male
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: Minimum experience of two years in the modality and to have been classified among the 10 first places in the categories of the tests realized in the state of Rio de Janeiro. Training frequency of at least 3 x per week including sessions of technical and physical training. Do not be users of anabolic steroids. Athletes consuming caffeine amounts ?300 mg.day (Fit et al., 2013).

Exclusion criteria

Exclusion criteria: Hypertensive athletes and those who present nausea, gastritis and osteomioarticular lesions will be excluded during the experiment.

Design outcomes

Primary

MeasureTime frame
Mean heart rate difference (analyzed by heart rate, ventilatory parameters) and output power (cycle on the cycle ergometer, athletes using caffeine or placebo).

Secondary

MeasureTime frame
Increase (10%) in blood lactate concentration, as measured by laboratory analysis after caffeine intervention and placebo.

Countries

Brazil

Contacts

Public ContactAnderson;Anderson Morales;Morales

Universidade Federal do Rio de Janeiro (UFRJ-Campus Macaé);Universidade Federal do Rio de Janeiro (UFRJ-Campus Macaé)

andersonmrl@hotmail.com;andersonmrl@hotmail.com+5522997087600;22997087600

Outcome results

None listed

Source: REBEC (via WHO ICTRP)